Data published in the Journal of the American College of Cardiology showed a high prevalence of definite infective endocarditis (IE) in patients with Enterococcus faecalis bacteremia (26%), suggesting that echocardiography should be considered in patients with E faecalis infection. A multicenter study using echocardiography was conducted from January 2014 to December 2016 in 344 consecutive…
The prevalence of infective endocarditis is about 26 percent among patients with Enterococcus faecalis bacteremia.
Early postoperative mortality may not differ between infective endocarditis caused by IDU and non- IDU causes.
A less restrictive criteria for the use of OPAT for patients with infective endocarditis than current IDSA guidelines was efficacious and safe.
Cefiderocol, a novel siderophore cephalosporin, may be successful in patients with persistently bacteremic nosocomial native aortic valve endocarditis.
The 2007 AHA recommendation for antibiotic prophylaxis for only patients at high risk for infective endocarditis may result in increased incidence of the infection.
There has been a marked increase in the rates of overall hospitalizations and hospital stays that include surgery for drug use-associated infective endocarditis.
A 9-point risk assessment (IVAT) identified persons with a history of injection drug use (IDU) safe for discharge and reduced the mean length of hospital stay (ALOS) by 20 days and total direct cost by 33%.
Acute endocarditis, lymphadenitis, and bone marrow involvement in hemophagocytic syndrome have been newly identified as Q fever foci.
Changing to oral antibiotics was non-inferior to continued intravenous antibiotic treatment
